Bruce I. Sachs - 02 Aug 2021 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
02 Aug 2021
Net transactions value
+$2,968,650
Form type
4
Filing time
04 Aug 2021, 16:05:43 UTC
Previous filing
16 Jul 2021
Next filing
18 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Purchase $2,968,650 +15,000 +57% $197.91 41,210 02 Aug 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market sales reported on this line occurred at a weighted average price of $197.91 (range $197.45 to $198.12).
F2 Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.